GORE® EXCLUDER® Iliac Branch Endoprosthesis Gains Health Canada Approval
Global reach expanded for the solution that physicians trust and patients count on
Apr 21, 2016
Gore Launches Unique Biomaterial for Complex Ventral Hernia Repair
Gore to launch its new hybrid device, GORE® SYNECOR Biomaterial, at the 17th Annual Hernia Repair Conference in Washington, D.C.
Mar 30, 2016
First Implant Completed in Thoracoabdominal Aortic Aneurysm Clinical Study
New investigative Gore device is designed to treat aortic aneurysms involving visceral branch vessels
Mar 12, 2016
Gore Again Named One of the 100 Best Companies to Work For®
Every year since 1998: That’s how long W. L. Gore & Associates has appeared on the Fortune 100 Best Companies to Work For® list
Mar 3, 2016
GORE® EXCLUDER® Iliac Branch Endoprosthesis Gains FDA Approval
Gore designed all-in-one system to preserve iliac artery blood flow in patients with iliac or aortoiliac aneurysms
Mar 3, 2016
First Patients Enrolled in the Gore RELINE MAX Clinical Study
108 patient trial to add evidence for treatment of in-stent restenosis using the GORE® VIABAHN® Endoprosthesis
Dec 16, 2015
Nominees Announced for 2016 Pioneers in Performance Awards for North America; Online Voting Opens at www.PioneersInPerformance.com
Awards program honors medical specialists advancing therapy and improving patient and clinical performance through active collaboration
Nov 18, 2015
GORE® EXCLUDER® Iliac Branch Endoprosthesis Exceeds 1,000 Implants Worldwide
Innovative system for managing common iliac artery aneurysms or aortoiliac aneurysms impacting lives around the world
Nov 17, 2015
GORE® EXCLUDER® Iliac Branch Endoprosthesis Exceeds 1,000 Implants Worldwide
Innovative system for managing common iliac artery aneurysms or aortoiliac aneurysms impacting lives around the world
Nov 17, 2015
Gore Achieves 40 Million Implants Sold Worldwide as it Celebrates 40 Years of Performance
Milestones a testament on its 40-year legacy of designing devices to improve patient outcomes
Nov 17, 2015